Search by Drug Name or NDC
NDC 72789-0211-01 Piroxicam 20 mg/1 Details
Piroxicam 20 mg/1
Piroxicam is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is PIROXICAM.
MedlinePlus Drug Summary
Piroxicam is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Piroxicam is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.
Related Packages: 72789-0211-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Piroxicam
Product Information
NDC | 72789-0211 |
---|---|
Product ID | 72789-211_f49aa3f1-5d44-5f11-e053-2995a90abe8c |
Associated GPIs | 66100070000110 |
GCN Sequence Number | 008371 |
GCN Sequence Number Description | piroxicam CAPSULE 20 MG ORAL |
HIC3 | S2B |
HIC3 Description | NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS |
GCN | 35821 |
HICL Sequence Number | 003732 |
HICL Sequence Number Description | PIROXICAM |
Brand/Generic | Generic |
Proprietary Name | Piroxicam |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Piroxicam |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/1 |
Substance Name | PIROXICAM |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA210347 |
Listing Certified Through | 2024-12-31 |
Package
NDC 72789-0211-01 (72789021101)
NDC Package Code | 72789-211-01 |
---|---|
Billing NDC | 72789021101 |
Package | 100 CAPSULE in 1 BOTTLE, PLASTIC (72789-211-01) |
Marketing Start Date | 2021-10-27 |
NDC Exclude Flag | N |
Pricing Information | N/A |